Cargando…

Expression of transcription factor AP-2α predicts survival in epithelial ovarian cancer

The 52-kDa activator protein (AP)-2 is a DNA-binding transcription factor which has been reported to have growth inhibitory effects in cancer cell lines and in human tumours. In this study the expression of AP-2α was analysed in 303 epithelial ovarian carcinomas by immunohistochemistry (IHC) with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anttila, M A, Kellokoski, J K, Moisio, K I, Mitchell, P J, Saarikoski, S, Syrjänen, K, Kosma, V-M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363243/ https://www.ncbi.nlm.nih.gov/pubmed/10864206 http://dx.doi.org/10.1054/bjoc.2000.1146

Ejemplares similares

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 α in cutaneous melanoma
por: Karjalainen, J M, et al.
Publicado: (2000)

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer
por: Anttila, M A, et al.
Publicado: (1999)

p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis
por: Ropponen, K M, et al.
Publicado: (1999)

Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival
por: Aaltomaa, S, et al.
Publicado: (1999)

Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma
por: Ito, I, et al.
Publicado: (2000)

Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
por: Hata, K, et al.
Publicado: (1999)

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
por: Sallinen, Hanna, et al.
Publicado: (2014)

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
por: Umemoto, M, et al.
Publicado: (2001)

Analysis of the TGFβ functional pathway in epithelial ovarian carcinoma
por: Francis-Thickpenny, K M, et al.
Publicado: (2001)

Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells
por: Dhar, K K, et al.
Publicado: (1999)

p21(WAF1/CIP1)expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
por: Karjalainen, J M, et al.
Publicado: (1999)

Hormone replacement therapy and risk of epithelial ovarian cancer
por: Purdie, D M, et al.
Publicado: (1999)

Analysis of radon-associated squamous cell carcinomas of the lung for ap53 gene hotspot mutation
por: Yang, Q, et al.
Publicado: (2000)

The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers
por: Kołat, Damian, et al.
Publicado: (2019)

Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
por: Setälä, L P, et al.
Publicado: (1999)

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
por: Vasey, P A, et al.
Publicado: (2001)

Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies
por: Akahira, J, et al.
Publicado: (2000)

α-Catenin expression has prognostic value in local and locally advanced prostate cancer
por: Aaltomaa, S, et al.
Publicado: (1999)

Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms
por: Munakata*, S, et al.
Publicado: (2000)

nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma
por: Schneider, J, et al.
Publicado: (2000)

Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression
por: Tuhkanen, Hanna, et al.
Publicado: (2009)

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868
por: Simpson, B J B, et al.
Publicado: (1999)

AP-1 Transcription Factor JunD Confers Protection from Accelerated Nephrotoxic Nephritis and Control Podocyte-Specific Vegfa Expression
por: Cook, H. Terence, et al.
Publicado: (2011)

Diurnal Cortisol and Survival in Epithelial Ovarian Cancer
por: Schrepf, Andrew, et al.
Publicado: (2015)

Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-α in human prostate cancer cells
por: Seth, D, et al.
Publicado: (1999)

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
por: Giatromanolaki, A, et al.
Publicado: (2001)

Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2022)

CDKN2A gene inactivation in epithelial sporadic ovarian cancer
por: Niederacher, D, et al.
Publicado: (1999)

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass
por: Vogl, F D, et al.
Publicado: (2000)

Clinicopathology of EpCAM and EGFR in Human Epithelial Ovarian Carcinoma
por: Zheng, Jingying, et al.
Publicado: (2017)

Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells
por: Guy, M, et al.
Publicado: (2001)

hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
por: Ercoli, A, et al.
Publicado: (1999)

Nurse leaders' work‐related well‐being—Relationships to a superior's transformational leadership style and structural empowerment
por: Niinihuhta, Milja, et al.
Publicado: (2022)

DNA topoisomerase IIα and -β expression in human ovarian cancer
por: Withoff, S, et al.
Publicado: (1999)

Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists
por: Chatzistamou, I, et al.
Publicado: (2000)

Increased activity of MAP, p70S6 and p90rs kinases is associated with AP-1 activation in spontaneous liver tumours, but not in adjacent tissue in mice
por: Ostrowski, J, et al.
Publicado: (2000)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Transcription factors AP-2α and AP-2β regulate distinct segments of the distal nephron in the mammalian kidney
por: Lamontagne, Joseph O., et al.
Publicado: (2022)

Direct activation of oestrogen receptor- α by interleukin-6 in primary cultures of breast cancer epithelial cells
por: Speirs, V, et al.
Publicado: (2000)

The Transcription Factor AP-1 Is Required for EGF-induced Activation of Rho-like GTPases, Cytoskeletal Rearrangements, Motility, and In Vitro Invasion of A431 Cells
por: Malliri, Angeliki, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_oumbti0344kd2ilpa1joc62dl1